Oral Immunotherapy for Treatment of Food Allergy: 2021 Update
This is an interactive course that provides information about the different types of food immunotherapy, with a focus on oral immunotherapy (OIT). We will review the history of OIT and examine the current evidence supporting OIT's use. We also will discuss the new FDA-approved peanut oral immunotherapy product and the importance of shared decision making with patients and families to identify which patients might benefit most from this therapy. This course also highlights the risks and limitations associated with OIT.
- Allied Health Professionals
Upon completion of this course, the learner will be able to:
- Discuss current understanding of food allergy testing to determine which patients qualify for oral food challenge vs. oral immunotherapy (OIT)
- Demonstrate understanding of the current pathophysiologic mechanisms of OIT
- Understand the use of FDA approved peanut OIT in clinical practice and the importance of shared decision making
- Identify risks and limitations associated with OIT
Justin C. Greiwe, MD
Bernstein Allergy Group, Cincinnati, OH
Relevant Relationships: None
Jonathan A. Hemler, MD FAAAAI
University of Virginia School of Medicine
Relevant Relationships: None
J. Andrew Bird, MD FAAAAI
University of Texas Southwestern Medical Center
Relevant Relationships: Abbott Nutritional International, Aimmune Therapeutics, AllerGenis, Allergy Therapeutics, Ltd., Astellas, DBV Technologies, FARE, Genentech, NIH-NIAID, Parm Olam International, Prota Therapeutics, Vindico Medical Education
Christina E. Ciaccio, MD FAAAAI
The University of Chicago
Relevant relationships: Aimmune: Speaker: AR101; DBV: Consultant: Viaskin patch
Samuel Gubernick, DO FAAAAI
Family Allergy, Asthma and Immunology Associates, Largo, FL
Relevant relationships: None
Jacob Daniel Kattan, MD FAAAAI
Icahn School of Medicine at Mount Sinai
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medium and Method of Physician Participation
Follow these steps to complete the activity:
- Register for the activity.
- Review the information in the Faculty and Accreditation tabs.
- Click Begin (from the Overview, Register, or Begin tabs).
- Complete the OIT module and the assessment. You must achieve a score of 70% or higher to claim credit.
- Complete the activity evaluation.
- Claim your credits.
- Print or save your certificate.
To verify your participation in live educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at email@example.com.
Activity-related questions should be directed to firstname.lastname@example.org.
- 0.50 AttendanceAttendance credit.
- 0.50 CMECME credit.
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari. Internet Explorer is no longer supported.
Pop-ups must be enabled in order to access all course content. The interactive course will pop up in a new window.